Smruthi Organics Receives ANVISA Inspection Report for Unit II API Facility
Smruthi Organics Ltd 路 Others (Uncategorized) 路 21 Oct 2026, 5:02 pm
Smruthi Organics Receives ANVISA Inspection Report for Unit II API Facility Smruthi Organics received an inspection report from the Brazilian Health Regulatory Agency (ANVISA) for its Unit II facility in Solapur, Maharashtra, following an audit conducted from 7th Jun'26 to 11th Jun'26. The facility was classified as "Complies with Good Manufacturing Practices with Corrective Action" and fulfills conditions for certification regarding the inspected active pharmaceutical ingredient (API). While final GMP certification remains pending receipt, the outcome marks a critical regulatory milestone toward securing market clearance in Brazil.
Original exchange filing (PDF)
More announcements from Smruthi Organics Ltd
- Outcome of Board Meeting : Unaudited Financial Results for the second quarter and half year ended 30th September 2026 路 13 Nov 2026
- Financial Results for quarter and half year ended 30.09.2026 路 13 Nov 2026
- Receipt of Brazilian Good Manufacturing Practices (GMP) Certificate 路 12 Nov 2026
- Smruthi Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Prior Intimation of Board .... 路 13 Nov 2026
- Approval from CG for appointment of Ms SmruthI eaga as Whoel Time Director 路 07 Oct 2026
- Scrutinisers Report and Voting Results of AGM 路 11 Aug 2026
- Outcome of 37th Annual General Meeting held today i.e 10th August 2026 路 10 Aug 2026
- Un Audited Quarterly Results of the Company for the first quarter ended 30th June 2026 路 10 Aug 2026
